Chargement en cours...
Reversal of Immunogenicity in Pediatric Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Medications
Loss of response to anti-tumor necrosis factor (anti-TNF) agents in the treatment of inflammatory bowel disease (IBD) is a major consideration to maintain sustained response. Reversal of immunogenicity can re-establish response and increase the durability of these agents. Strategies to reverse immun...
Enregistré dans:
| Publié dans: | Pediatr Gastroenterol Hepatol Nutr |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6182480/ https://ncbi.nlm.nih.gov/pubmed/30345247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5223/pghn.2018.21.4.329 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|